<DOC>
	<DOCNO>NCT00216476</DOCNO>
	<brief_summary>The purpose study investigate whether long-acting injectable formulation risperidone provide good effectiveness 2 year , measure time relapse , compare quetiapine tablet routine psychiatric care set . Aripiprazole investigate descriptive manner .</brief_summary>
	<brief_title>A Study Relapse Prevention Effectiveness Long-acting Injectable Risperidone Quetiapine Tablets Treatment Patients With Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description>Although many schizophrenia patient currently take oral antipsychotic medication , estimate 75 % difficulty adhere daily oral regimen . Long-acting injectable formulation may eliminate need daily medication enhance patient compliance treatment regimen . This open-label ( people involve know identity intervention ) , randomize ( study drug assign chance ) study formulation risperidone ( coated microspheres ) inject muscle 2 week interval 104 week stable patient schizophrenia schizoaffective disorder , treat oral risperidone , olanzapine , conventional antipsychotic agent . A comparator group receive tablet quetiapine take 2 3 time daily , depend optimal dosage . In country aripiprazole available , aripiprazole also include descriptive manner . Reasons switch symptomatically stable patient current antipsychotic treatment include insufficient effectiveness medication symptom , adverse event , patient 's request . The principal measure effectiveness drug time relapse . Assessments effectiveness also include : Positive Negative Syndrome Scale ( PANSS ) , measure symptom schizophrenia ; overall severity illness measure Clinical Global Impression subscale ( CGI-S ) ; patient 's condition measure Clinical Global Impression condition subscale ( CGI-C ) ; quality life assess SF-12 survey . Safety evaluation include incidence adverse event , Extrapyramidal Symptoms Rating Scale ( ESRS ) , clinical laboratory test ( biochemistry , haematology , urinalysis ) , vital sign ( pulse , blood pressure ) . The study hypothesis treatment long-acting risperidone inject intramuscularly every 2 week provide good effectiveness quetiapine , measure time relapse , patient schizophrenia schizoaffective disorder . Risperidone injections 25mg biweekly 104 week , increase decreasing ( increment 12.5mg ) investigator 's discretion . Risperidone tablet ( 2mg daily 2 day ) patient start risperidone . Quetiapine Aripiprazole use accord package insert .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Diagnosis schizophrenia schizoaffective disorder accord Diagnostic Statistical Manual Mental Diseases , 4th edition ( DSMIV ) Patients currently treat oral risperidone , olanzapine conventional neuroleptic monotherapy dose exceed 6 mg risperdal , 20 mg olanzapine , conversion dose 10 mg haloperidol oral conventional agent Patients stable ( judge clinically stable investigator stable dose medication 4 week longer ) optimally treat ( nonsatisfactory treatment regard symptom adverse event ) Diagnosis schizophrenia schizoaffective disorder DSMIV Axis I criteria Patients treat antipsychotic agent oral risperidone , olanzapine conventional oral neuroleptic agent Patients know hypersensitivity oral risperidone , quetiapine , aripiprazole , know nonresponders oral risperidone , quetiapine , aripiprazole previous treatment least 2 antipsychotic agent Patients treat mood stabilizer antidepressant stable dose least 3 month study initiation Pregnant nursing female , lack adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Schizophrenia , relapse prevention</keyword>
	<keyword>Antipsychotic agent</keyword>
	<keyword>Long-acting risperidone</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Aripiprazole</keyword>
</DOC>